Ramsay Health Care share price on watch amid Bupa contract termination

Ramsay is playing hardball with Bupa…

| More on:
Female doctor with a mask holds out hand in a stop gesture.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Ramsay is terminating its contract with private health insurer Bupa
  • It wants a fairer deal as it battles rising costs and private health insurers watch their profits swell
  • Bupa customers may have to switch health funds to get treatment from Ramsay in the future

The Ramsay Health Care Limited (ASX: RHC) share price will be one to watch on Thursday.

This follows the release of an announcement after the market close today in relation to a contract termination.

Why is the Ramsay share price on watch?

This afternoon Ramsay revealed that it has issued a notice to private health insurance provider Bupa to terminate the Hospital Purchaser Provider Agreement between the two parties.

According to the release, unless a resolution is reached between the parties, Ramsay's contract with Bupa will be terminated with effect from 2 August 2022.

Ramsay appears to believe that private health insurers are not pulling their weight despite accumulating huge profits.

"Costs of providing care have significantly increased for private hospitals over the past two years. On the other hand, health insurers have accumulated profits of $1.8 billion in the calendar year to 31 December 2021," said Ramsay Australia CEO Carmel Monaghan.

What's next?

The release explains that patients booked to be admitted to a Ramsay facility prior to 2 August will not be impacted. After that date, during a legally enforced transitional period, Ramsay will continue to accept benefits paid by Bupa for approved treatments.

However, once the transitional period ends, Bupa insured patients will be required to pay an upfront payment on admission. This will be the difference between the statutory default benefit Bupa is required to pay and Ramsay's hospital treatment costs.

Ms Monaghan said that "Ramsay still hopes to reach agreement with Bupa prior to the contract termination date," but this appears to be far from guaranteed.

The private hospital operator advised that it will be communicating with impacted patients to keep them informed and provide them with options which, in light of the portability rules in the Private Health Insurance Act, include leaving Bupa and changing health funds.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Doomed takeover bid for Mayne Pharma to come to an end

The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the…

Read more »